|
ORGANIZING COMMITTEE
- Kathy Kinsey - Rensselaer Polytechnic Institute (Troy, NY)
- Susan Gilbert, PhD - Rensselaer Polytechnic Institute (Troy, NY)
- Leon Radomsky, MS, JD - Foley & Lardner (Washington, DC)
- Phyllis Gardner, MD - Stanford University School of Medicine (Stanford, CA)
- Chuck Rancourt - Rensselaer Polytechnic Institute (Troy, NY)
- Annette I. Kahler, JD - Albany Law School (Albany NY)
- Michael Reed, PhD, JD - Buchanan, Ingersoll & Rooney (San Diego, CA)
- Drew Harris, JD - Dougherty, Hearon & Moody (Austin, TX)
- S. R. Bawa, PhD - Bawa Biotechnology Consulting (Schenectady, NY)
- Ginger Gruters - The President’s Council on Bioethics (Washington, DC)
- John Miller, JD - Arrowhead Research Corporation (Pasadena, CA)
- Justin Hanes, PhD - Johns Hopkins University (Baltimore, MD)
- Chid Iyer, MS, JD - Sughrue Mion (Washington, DC)
- Oscar Ellison, MD - Atlantic Medical (Fairfax, VA)
- Mark Hayman, PhD, JD - Cooley, Godward & Kronish (Washington, DC)
- Raj Bawa, MS, PhD - Bawa Biotechnology Consulting (Ashburn, VA); Rensselaer Polytechnic Institute (Troy, NY) Chair
CONFERENCE PROGRAM
On-site Registration and Media Interviews: 8:00am – 9:00am
Introduction and Welcome: 9:00am
Jeffrey M. Schanz
Assistant Vice President for Alumni Relations
Executive Director of the Rensselaer Alumni Association
Rensselaer Polytechnic Institute (Troy, NY)
Conference Chair’s Opening Remarks: 9:15am
Raj Bawa, PhD
Patent Agent, Bawa Biotechnology Consulting (Arlington, VA)
Adjunct Associate Professor, Rensselaer Polytechnic Institute (Troy, NY)
Director of Nanotechnology, Mots Law PLLC (Washington DC)
 Opening Keynote: 9:20am – 9:50am
Nanocomposites for Biocompatible Power Storage in Medicine
Robert J. Linhardt, PhD
Senior Constellation Professor, Professor of Chemical and Biological Engineering, Professor of Chemistry and Chemical Biology, Professor of Biology,
Acting Director of the Center for Biotechnology and Interdisciplinary Studies
Rensselaer Polytechnic Institute (Troy, NY)
Session 1: Innovations in NanoBiotech and Nanomedicine
9:50am – 11:30am (Moderator: Raj Bawa)
Nanoparticle-based Therapeutics in Humans – A 15-Minute Survey
Raj Bawa, PhD
Patent Agent, Bawa Biotechnology Consulting (Arlington, VA)
Adjunct Associate Professor, Rensselaer Polytechnic Institute (Troy, NY)
Director of Nanotechnology, Mots Law PLLC (Washington DC)
Bio/Nano Materials Innovation at Rensselaer
Michael D. Wright
Associate Director
Rensselaer Nanotechnology Center
Rensselaer Polytechnic Institute (Troy, NY)
Theranostic Nanoparticles as image-based biomarkers and targeted
drug delivery vehicles for tumor angiogenesis
Shelton D. Caruthers, PhD
Senior Clinical Scientist and Director of Sites
Clinical Research Board, Philips Healthcare
Associate Director, Cardiovascular MR Laboratories
Washington University School of Medicine (St. Louis, MO)
Nanotechnology for Nanomedicine –
Use of IC Wafer Fabrication Methods for Bio-Research
James Castracane, PhD
Professor and Head of Nanobiosciences
Director of the Center for Nanomaterials and Nanoelectronics
University at Albany-SUNY (Albany, NY)
Molecular Ion Pumps
Blanca Barquera, PhD
Assistant Professor of Biology
Rensselaer Polytechnic Institute (Troy, NY)
Survivin’ Antagonists in Cancer Therapy via Nanocarrier Delivery –
In Vitro and In Vivo Studies
Jagat R. Kanwar, PhD
Associate Professor of Immunology and Cell Biology
Institute of Biotechnology, Deakin University (Australia)
Networking Break (10 minutes)
Invited Keynote 1: 11:40am – 12:10pm
Materializing the Potential of Molecular Medicine via a Tumor-Targeting Nanodelivery Platform
Esther H. Chang, PhD
Professor of Oncology, Lombardi Cancer Center, Georgetown University School of Medicine (Washington, DC)
Professor of Pathology and Surgery, Uniformed Services University of the Health Sciences (Bethesda, MD)
Session 2: Nanotechnology Law and Business
12:10pm – 1:20pm (Moderator: Leon Radomsky)
Reforming the Patent System – Impact on Nanotech
Leon Radomsky, MS, JD
Partner and Chair of the Nanotechnology Industry Team
Foley & Lardner LLP (Washington, DC)
Intellectual Property as Collateral – Security Interests in IP
Jeffery P. Langer, PhD
Patent Agent
Finnegan LLP (Washington, DC)
Nanobiotechnology Patents – The Position in Europe
Robert Harrison, PhD, JD
Partner, 24IP Law Group (Munich, Germany)
What is Obvious? -- Nanotechnology and Current Case Law
David M. Longo, PhD, JD
Associate
Finnegan LLP (Washington, DC)
Making Your Nanotech Intellectual Assets Attractive to Investors
Konstantina M. Katcheves, MS, JD
Patent Counsel, Saul Ewing LLP (Baltimore, MD)
 Networking Lunch: 1:20pm – 2:15pm
Raffle Drawings – 2:15pm
Invited Keynote 2: 2:20pm – 2:50pm
Biohazard Early Warning System using a Nanotech-based Biosensor from NASA
Neil Gordon, MBA, PEng
President and CEO
Early Warning, Inc. (Montreal, Canada)
Session 3: Current Issues in NanoBiotech
2:50pm – 4:30pm (Moderator: Glenn Monastersky)
Bionanotechnology -- Global Prospects
David E. Reisner, PhD
CEO
The Nano Group (Farmington, CT)
Understanding the Ethical Implications of Nanotech –
Highlights of an Inquiry by The President’s Council on Bioethics
Ginger Gruters
The President’s Council on Bioethics (Washington, DC)
Women in Nanotechnology
Annette I. Kahler, JD
Visiting Assistant Professor of Law
Director, Science & Technology Law Center
Albany Law School (Albany, NY)
Nanoparticles – Biosafety Issues
Glenn Monastersky, PhD
Director of Operations, Center for Biotechnology and Interdisciplinary Studies
Rensselaer Polytechnic Institute (Troy, NY)
How Does the Human Body Handle NanoPharmaceuticals?
Srikumaran Melethil, PhD, JD
Chair and Professor of Pharmaceutical Sciences
School of Pharmacy, University of Findlay (Findlay, OH)
Challenges of Nano-Delivery in Airway Diseases – Bypassing the Mucus Barrier
Neeraj Vij, MS, PhD
Assistant Professor, Department of Pediatrics-Pulmonary
Institute for NanoBioTechnology
Johns Hopkins University School of Medicine (Baltimore, MD)
Conclusion of Conference – 4:30pm
|
